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BACKGROUND
Maturation of eosinophils takes place in bone marrow.
After 5–6 days of maturation, eosinophils pass to the
bloodstream. In the blood eosinophils circulate for only
3–8 hours and enter the tissues. A mature eosinophil cell
is 10–15 mm large, with characteristically divided nucleus
and multiple granules. There are two types of eosinophils
with different activity. In healthy subjects, 90% of all cir-
culating esinophils are non-active eosinophils [1]. In
patients with atopy, the number of activated eosinophils
increases and amounts up to 60 percent [2]. The pato-
physiologic role of eosinophils is connected with deliv-
ered mediators. There are two types of mediators:
released from cytoplasmatic granules and produced ad
hoc during prolonged activation. According to the recent
studies, cytoplasmatic granules mediators which play the
main role in the pathophysiologic processes are: MBP –
main basic protein, EPO – eosinophil peroxidase, ECP –
eosinophil cationic protein, EDN- eosinophil-derived
neurotoxin (which is also called EPX – eosinophil protein
X). The mediators produced during prolonged activation
include: leukotrien C4, platelet activating factor (PAF)
and cytokines (IL-1a, IL-3, IL-5, TNF-α, GM-CSF) [1].
ECP and EPX are clinically important and easily mea-
surable mediators. ECP possesses strong cytotoxic activi-
ty, but it can also decrease the proliferation of lympho-
cytes T [3,4].
An increased ECP concentration was demonstrated in
patients with bronchial asthma [5,6]. There is a clear
correlation between severity of the disease and ECP
concentration. Moreover, ECP concentration can be
used for monitoring severity of asthma and response to
treatment [7,8].
An increased ECP concentration and an increased num-
ber of eosinophils were also observed in infants with res-
piratory syncitial virus infection and increased ECP con-
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Summary
Background: Eosinophilia is a common finding in neonatal units. The role of eosinophilia in preterm infants is uncertain. The aim
of the study was the assessment of absolute eosinophil count (AEC) and eosinophil cationic protein (ECP) concentration in the blood of
VLBW infants during the first 4 weeks of life.
Material and Methods: Prospective study in the University Hospital NICU included 58 preterm infants with gestational age 24–34
weeks (x±SEM: 28.8±0.3) and mean birth weight 1127±31 g. AEC, ECP ant total IgE levels at admission, and at the age of 10,
20 and 30 days of life were measured.
Results: There were no correlations between AEC and gestational age (R=0.14, p=0.33) or birth weight (R=0.13, p=0.34), and
between ECP and gestational age (R=-0.05, p=0.8) or birth weight (R=0.11; p=0.53) either. There were significant correlations
between AEC and ECP at admission (R=0.46; p=0.001) and after the 5th day of life (R=0.51; p<0.001). AEC > 1500/mm3 was
observed in 26 (44%) children. Significant eosinophilia was recognized on average on the 24th day of life. Only 3 children had posi-
tive total IgE levels (>2kU/l). There were no correlations between AEC or ECP and total IgE levels.
Conclusions: There is a correlation between AEC and ECP confirming that an increased number of eosinophils in preterm infants is
connected with increased activity of eosinophils.
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centration was used as a predictor of future asthma
development [9–12].
Eosinophilia is a common finding in neonatal units [13],
but the role of eosinophilia in infants is uncertain.
Moreover, there is no available data evaluating activity
of eosinophils in preterm infants. Additionally, the data
analyzing correlation between eosinophilia in early
infancy and future development of allergy is insuffi-
cient. Prematurity is an important risk factor of chronic
lung disease and hyperreactivity of airways. There exists
a hypothesis stating that eosinophil activation observed
in neonates can be a sign of a specific way in which the
child responds to stimulation, the way which can predict
the development of asthma in future life.
The aim of the study was the assessment of absolute
eosinophil count (AEC) and eosinophil cationic protein
concentration in the blood of very low birth weight
infants during the first 4 weeks of life.
MATERIAL AND METHODS
Subjects
Over the period of 18 months (June 2001 – December
2002) 58 newborns were recruited to the study. Inclusion
criteria were as follows: (a) birthweight (1500 g, (b) age at
admission <72 hours. The only exclusion criteria were
early sepsis and multiple congenital malformations.
Intervention
At admission, and at the age of 10th, 20th and 30th day of
life AEC, ECP and total IgE levels were evaluated. ECP
concentration was analyzed by radioimmunoassay (Pha-
rmacia, Upsala, Sweden).
Statistical analysis
Categorical variables were statistically analyzed using a
chi-square test or a Fischer exact test. Continuous varia-
bles were analyzed using a t-student test or Mann-
-Whitney U-test. Statistica for Windows statistical software
version 6.0PL (StatSoft, Inc.2001) was used for the analy-
ses, and p<0.05 was considered statistically significant.
RESULTS
Basic characteristic of the studied infants is presented in
Table 1. Birth weight of 22 (38%) newborns was less than
1000 g. At admission, AEC and ECP were evaluated in all
patients (Table 2.). In infants admitted after 1.02.2002
total IgE level was also analyzed.
At admission, there were no correlations between AEC
and gestational age (R=0,14, p=0.33) or birth weight
(R=0.13, p=0.34). Additionally, there were no correla-
tions between ECP and gestational age (R=–0.05,
p=0.8) or birth weight (R=0.11; p=0.53).
Birth weight, mean (SEM)
Gestational age, mean (SEM)
Female
Vaginal delivery
Small for gestational age
Mechanical ventilation at admission
1127 g (31)
28.8 weeks (0.3)
28 (48)
25 (43)
7 (12)
41 (71)
Table 1. Baseline characteristics of study participants*.
* expressed as a number (percentage) of patients unless otherwise indicated
Median Mean SEM Range
WBC (/mm3)
Eosinophils (%)
Absolute eosinophil
count (/mm3)
ECP concentration
(ng/ml)
10,600
1.5
100
5
14,250
1
188
16.5
1,200
0.2
37
6.3
2,700–64,600
0–8
0–2380
2–77.8
Table 2. Laboratory data at admission.
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Figure 1. Correlation between absolute eosinophil count and concen-
tration of eosinohil cationic protein at admission.
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Figure 2. Correlation between absolute eosinophil count and concen-
tration of eosinohil cationic protein after the 5th day of life.
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AEC (Me: 0 vs 80 /mm3, p=0.8) and ECP concentrations
(Me: 13.7 vs 9.7 ng/ml; p=0.5) were similar in the
groups of newborns: 1) with mechanical ventilation and
2) without mechanical ventilation.
There were significant correlations between AEC and
ECP at admission (R=0.46; p=0.001 – Figure 1.) and
after 5th day of life (R=0.51; p<0.001 – Figure 2.).
During the study 666 complete blood counts were per-
formed. Significant eosinophilia (AEC >1500/mm3) was
observed in 26 (44%) children. In 8 cases eosinophilia was
recognized on more than 2 occasions, but in 16 infants it
was detected only once. Significant eosinophilia was
observed (Me) on the 24th day of life. The correlation
between absolute eosinophil count and the calendar age of
studied infants is presented in Figure 3. The comparison
of selected variables between patients with and without sig-
nificant (>1500/mm3) eosinophilia is presented in Table 3.
Only 3 children had positive total IgE levels (>2kU/l).
There were no correlations between AEC or ECP and
total IgE levels.
DISCUSSION
Bhat et al. in 1981 recognized that 75% preterm infants
had an absolute eosinophil count higher than 700/mm3
[14]. Moreover, Sharma et al. noted that the prevalence of
eosinophilia is higher in extremely preterm newborns
[15]. Our results confirmed these observations. Significant
eosinophilia (>1500/mm3) was recognized in 44% infants,
with high incidence between the 20th and 40th day of life.
Interestingly, there were no correlations between AEC
and gestational age or birth weight.
The analysis of risk factors of eosinophilia in preterm
neonates was performed by Fayon et al. [16]. The
authors noted that the risk of eosinophilia is higher in
infants receiving multiple red blood transfusions, pro-
longed parental nutrition or mechanical ventilation.
Until now, there is no explanation for such a coinci-
dence.
Other results were presented by Ehara et al. [17]. The
authors analyzed correlation between medical proce-
dures (mechanical ventilation, antibiotics use, vein
catheterization, type of feeding) and prevalence of
eosinophilia. Only a correlation between erythropoietin
treatment and AEC was observed. But, all available
papers discussed only eosinophil count, not mentioning
the activity of eosinophils.
In the present paper, we analyzed eosinophil activity by
evaluating eosinophil cationic protein concentration in the
blood. We did not find any correlation between ECP con-
centration and gestational age and birthweight. Neither
mechanical ventilation or asphyxia influenced ECP con-
centrations. However, we have found a significant correla-
tion between AEC and ECP at admission and after the 5th
day of life. These observations confirm that the increased
number of eosinophils in preterm infants is connected with
the increased activity of eosinophils. There were no corre-
lations between AEC or ECP and total IgE levels, which
can suggest that the activation of eosinophils in neonates is
not connected with IgE production, and eosinophilia in
neonates does not predict the development of atopy.
The ECP and EPX concentrations in the nasal aspirates
in the 1st month of life were evaluated in prospective,
multicenter SPACE study [18]. The authors recognized
higher ECP and EPX concentrations in infants with pos-
itive family history for atopy.
Yamamoto et al. [19] performed a study comparing 10
neonates with severe bronchopulmonary dysplasia and 7
newborns with other respiratory failure. The ECP con-
centrations both in the blood and tracheal aspirates were
significantly higher in babies with BPD. The results men-
tioned above were confirmed by Raghavender et al. [20].
The authors suspected that the increased number of
eosinophils in preterm infants was connected with the
increased activity of eosinophils, which is also related to
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Figure 3. Correlation between absolute eosinophil count and calendar
age of studied infants.
Expressed as a number (percentage) of patients unless otherwise indicated.
There were no differences between the groups by:
* t-student test; ** chi-square test
Patient with
significant
eosinophilia
(n=26)
Patients
without
significant
eosinophilia
(n=32)
Birtweight, mean (SEM), g
Gestational age, mean (SEM), wks.
Female
Vaginal delivery
Small for gestational age
Mechanical ventilation at admission
Bronchopulmonary dysplasia
1092 (36)
28.4 (0.36)
12 (46)
10 (40)
2 (8)
20 (77)
9 (35)
1155 (37)*
29 (0.37)*
16 (50)**
15 (47)**
5 (15)**
21 (67)**
9 (28)**
Table 3. Comparison of selected variables between patients with
and without significant (>1,500/mm3) eosinophilia.
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the increased risk of developing bronchopulmonary dys-
palsia. Our results did not confirm such observation, but
we measured ECP concentration in the blood only.
CONCLUSIONS
1. There is no correlation between AEC and gestational
age or birth weight. Additionally, there is no correla-
tion between ECP and gestational age or birthweight.
2. Absolute eosinophil count is changing during the first
2 months of life.
3. Risk factors of eosinophilia in preterm infants are
uncertain.
There is a correlation between AEC and ECP confirm-
ing that the increased number of eosinophils in preterm
infants is connected with the increased activity of
eosinophils.
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